275 related articles for article (PubMed ID: 36637615)
1. Targeting the epigenome of cancer stem cells in pediatric nervous system tumors.
Freire NH; Jaeger MDC; de Farias CB; Nör C; Souza BK; Gregianin L; Brunetto AT; Roesler R
Mol Cell Biochem; 2023 Oct; 478(10):2241-2255. PubMed ID: 36637615
[TBL] [Abstract][Full Text] [Related]
2. Histone methyltransferase G9a and H3K9 dimethylation inhibit the self-renewal of glioma cancer stem cells.
Tao H; Li H; Su Y; Feng D; Wang X; Zhang C; Ma H; Hu Q
Mol Cell Biochem; 2014 Sep; 394(1-2):23-30. PubMed ID: 24833465
[TBL] [Abstract][Full Text] [Related]
3. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.
Tu Y; Gao X; Li G; Fu H; Cui D; Liu H; Jin W; Zhang Y
Cancer Res; 2013 Oct; 73(19):6046-55. PubMed ID: 23950210
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of tumor cells with stem-like properties in pediatric brain tumors.
Thirant C; Bessette B; Varlet P; Puget S; Cadusseau J; Tavares Sdos R; Studler JM; Silvestre DC; Susini A; Villa C; Miquel C; Bogeas A; Surena AL; Dias-Morais A; Léonard N; Pflumio F; Bièche I; Boussin FD; Sainte-Rose C; Grill J; Daumas-Duport C; Chneiweiss H; Junier MP
PLoS One; 2011 Jan; 6(1):e16375. PubMed ID: 21297991
[TBL] [Abstract][Full Text] [Related]
6. NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of all-trans retinoic acid via targeting RDH16 in malignant glioma.
Hu PS; Xia QS; Wu F; Li DK; Qi YJ; Hu Y; Wei ZZ; Li SS; Tian NY; Wei QF; Shen LJ; Yin B; Jiang T; Yuan JG; Qiang BQ; Han W; Peng XZ
Oncogene; 2017 Aug; 36(33):4706-4718. PubMed ID: 28394339
[TBL] [Abstract][Full Text] [Related]
7. The developmental origin of brain tumours: a cellular and molecular framework.
Azzarelli R; Simons BD; Philpott A
Development; 2018 May; 145(10):. PubMed ID: 29759978
[TBL] [Abstract][Full Text] [Related]
8. Developmental origins and oncogenic pathways in malignant brain tumors.
Lu QR; Qian L; Zhou X
Wiley Interdiscip Rev Dev Biol; 2019 Jul; 8(4):e342. PubMed ID: 30945456
[TBL] [Abstract][Full Text] [Related]
9. Targeting cancer stem cells through L1CAM suppresses glioma growth.
Bao S; Wu Q; Li Z; Sathornsumetee S; Wang H; McLendon RE; Hjelmeland AB; Rich JN
Cancer Res; 2008 Aug; 68(15):6043-8. PubMed ID: 18676824
[TBL] [Abstract][Full Text] [Related]
10. Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis.
Carlsson E; Krohn K; Ovaska K; Lindberg P; Häyry V; Maliniemi P; Lintulahti A; Korja M; Kivisaari R; Hussein S; Sarna S; Niiranen K; Hautaniemi S; Haapasalo H; Ranki A
Genes Chromosomes Cancer; 2013 Feb; 52(2):191-201. PubMed ID: 23097141
[TBL] [Abstract][Full Text] [Related]
11. Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues.
Zhou D; Alver BM; Li S; Hlady RA; Thompson JJ; Schroeder MA; Lee JH; Qiu J; Schwartz PH; Sarkaria JN; Robertson KD
Genome Biol; 2018 Mar; 19(1):43. PubMed ID: 29587824
[TBL] [Abstract][Full Text] [Related]
12. Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes.
Baxter PA; Lin Q; Mao H; Kogiso M; Zhao X; Liu Z; Huang Y; Voicu H; Gurusiddappa S; Su JM; Adesina AM; Perlaky L; Dauser RC; Leung HC; Muraszko KM; Heth JA; Fan X; Lau CC; Man TK; Chintagumpala M; Li XN
Acta Neuropathol Commun; 2014 Dec; 2():160. PubMed ID: 25526772
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of JMJD6 expression reduces the proliferation, migration and invasion of neuroglioma stem cells.
Zhou DX; Zhou D; Zhan SQ; Wang P; Qin K; Gan W; Lin XF
Neoplasma; 2017; 64(5):700-708. PubMed ID: 28592121
[TBL] [Abstract][Full Text] [Related]
14. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
15. Analysis of stemness gene expression and CD133 abnormal methylation in neuroblastoma cell lines.
Schiapparelli P; Enguita-Germán M; Balbuena J; Rey JA; Lázcoz P; Castresana JS
Oncol Rep; 2010 Nov; 24(5):1355-62. PubMed ID: 20878131
[TBL] [Abstract][Full Text] [Related]
16. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
Zhao B; Bian EB; Li J; Li J
J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
[TBL] [Abstract][Full Text] [Related]
17. [Phenotype of SHG-44 glioma stem cell spheres and pathological characteristics of their xenograft tumors].
Wu TF; Chen JM; Chen SS; Chen GL; Wei YX; Xie XS; Du ZW; Zhou YX
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):726-31. PubMed ID: 24378091
[TBL] [Abstract][Full Text] [Related]
18. Drug repurposing towards targeting cancer stem cells in pediatric brain tumors.
Bahmad HF; Elajami MK; El Zarif T; Bou-Gharios J; Abou-Antoun T; Abou-Kheir W
Cancer Metastasis Rev; 2020 Mar; 39(1):127-148. PubMed ID: 31919619
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA142-3p promotes tumor-initiating and radioresistant properties in malignant pediatric brain tumors.
Lee YY; Yang YP; Huang MC; Wang ML; Yen SH; Huang PI; Chen YW; Chiou SH; Lan YT; Ma HI; Shih YH; Chen MT
Cell Transplant; 2014; 23(4-5):669-90. PubMed ID: 24816458
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cells in pediatric brain tumors.
Lasky JL; Choe M; Nakano I
Curr Stem Cell Res Ther; 2009 Dec; 4(4):298-305. PubMed ID: 19500067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
